Does USTEKINUMAB Cause Joint stiffness? 617 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 617 reports of Joint stiffness have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.7% of all adverse event reports for USTEKINUMAB.
617
Reports of Joint stiffness with USTEKINUMAB
0.7%
of all USTEKINUMAB reports
334
Deaths
227
Hospitalizations
How Dangerous Is Joint stiffness From USTEKINUMAB?
Of the 617 reports, 334 (54.1%) resulted in death, 227 (36.8%) required hospitalization, and 214 (34.7%) were considered life-threatening.
Is Joint stiffness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 617 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Joint stiffness?
ADALIMUMAB (3,927)
ETANERCEPT (2,944)
METHOTREXATE (2,304)
TOFACITINIB (1,819)
TOCILIZUMAB (1,749)
ABATACEPT (1,385)
RITUXIMAB (1,366)
LEFLUNOMIDE (1,228)
HYDROXYCHLOROQUINE (1,206)
SULFASALAZINE (1,167)
Which USTEKINUMAB Alternatives Have Lower Joint stiffness Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE